Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Phase Two”

35,196 trials

Showing 20 of 35,196 results

Testing effectiveness (Phase 2)Study completedNCT06513364
What this trial is testing

Neoadjuvant Chemotherapy With WH002 in Women With HER2-negative Breast Cancer

Who this might be right for
Breast Cancer
Beijing Wehand-Bio Pharmaceutical Co., Ltd 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT05547464
What this trial is testing

Safety and Immune Responses After Vaccination With Two Investigational RNA-based Vaccines Against Tuberculosis in BCG Vaccinated Volunteers

Who this might be right for
Tuberculosis
BioNTech SE 497
Testing effectiveness (Phase 2)Study completedNCT01386632
What this trial is testing

Study of DCA (Dichloroacetate) in Combination With Cisplatin and Definitive Radiation in Head and Neck Carcinoma

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
Sanford Health 50
Testing effectiveness (Phase 2)UnknownNCT03684863
What this trial is testing

Capecitabine in HER-2 Positive Breast Cancer With Pathologic Residual Tumors After Preoperative Chemotherapy

Who this might be right for
HER2-positive Breast Cancer
Shandong Cancer Hospital and Institute 200
Testing effectiveness (Phase 2)Study completedNCT00149214
What this trial is testing

Preoperative Treatment of Breast Cancer With Two Different Sequential Treatment Regimens

Who this might be right for
Breast Cancer
Eli Lilly and Company 257
Testing effectiveness (Phase 2)UnknownNCT05133349
What this trial is testing

A Prospective Phase II Efficacy and Safety Study of Anlotinib in Metastatic or Locally Advanced Pheochromocytoma/ Paraganglioma : Open-label Single-arm, Exploratory Trial

Who this might be right for
Advanced or Metastatic Paraganglioma/ Pheochromocytoma
Nanjing First Hospital, Nanjing Medical University 20
Testing effectiveness (Phase 2)WithdrawnNCT02033538
What this trial is testing

Neoadjuvant Chemotherapy of Nanoparticle Albumin-bound Paclitaxel in Squamous Cell Carcinoma of Esophagus

Who this might be right for
Squamous Cell Carcinoma of Esophagus
Zhejiang University
Testing effectiveness (Phase 2)UnknownNCT02639858
What this trial is testing

Study to Evaluate the Efficacy and Safety of Docetaxel Polymeric Micelle (PM) in Recurrent or Metastatic HNSCC

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Samyang Biopharmaceuticals Corporation 31
Testing effectiveness (Phase 2)Study completedNCT00887458
What this trial is testing

A Two-dose Level Clinical Trial of Itraconazole in Patients With Metastatic Prostate Cancer Who Have Had Disease Progression While on Hormonal Therapy

Who this might be right for
Prostate Cancer
Johns Hopkins University 46
Early research (Phase 1)Study completedNCT01330758
What this trial is testing

Compare Two Different Tablet Formulations of AZD8931 in Healthy Males and Females

Who this might be right for
Healthy
AstraZeneca 26
Testing effectiveness (Phase 2)Study completedNCT00684515
What this trial is testing

Trial to Assess the Safety of Vorapaxar in Japanese Subjects With Cerebral Infarction (P05005; MK-5348-017)

Who this might be right for
Cerebral Infarction
Merck Sharp & Dohme LLC 90
Testing effectiveness (Phase 2)UnknownNCT06558708
What this trial is testing

A Trial Comparing Efficacy, Tolerability, and Safety of GZR101 Injection Once Daily (OD) and GZR33-70 Injection OD

Who this might be right for
Type 2 Diabetes
Gan and Lee Pharmaceuticals, USA 60
Large-scale testing (Phase 3)Active Not RecruitingNCT04655976
What this trial is testing

Efficacy Comparison of Cobolimab + Dostarlimab + Docetaxel to Dostarlimab + Docetaxel to Docetaxel Alone in Participants With Advanced Non-small Cell Lung Cancer Who Have Progressed on Prior Anti-PD-(L)1 Therapy and Chemotherapy

Who this might be right for
Lung Cancer, Non-Small Cell
GlaxoSmithKline 758
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07778940
What this trial is testing

Thiotepa Administration Via Ommaya Reservoir for Leptomeningeal Metastases in Non-Small Cell Lung Cancer Resistant to EGFR-TKI.

Who this might be right for
Leptomeningeal Metastasis
Tianjin Medical University Cancer Institute and Hospital 50
Testing effectiveness (Phase 2)Ended earlyNCT01748240
What this trial is testing

Addition of Vorinostat to Azacitidine in Higher Risk MDS a Phase II add-on Study in Patients With Azacitidine Failure

Who this might be right for
Myelodysplastic Syndrome
Groupe Francophone des Myelodysplasies 21
Testing effectiveness (Phase 2)Study completedNCT00942734
What this trial is testing

Trial of RAD001 and Erlotinib With Recurrent Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head And Neck Cancer
M.D. Anderson Cancer Center 49
Testing effectiveness (Phase 2)Study completedNCT00857532
What this trial is testing

Florbetapir F 18 PET Imaging of Beta-amyloid in Parkinson's Disease Patients

Who this might be right for
Parkinson's Disease
Avid Radiopharmaceuticals 31
Testing effectiveness (Phase 2)Study completedNCT03341832
What this trial is testing

Efficacy and Safety of NVP-1203 in Patients With Acute Low Back Pain

Who this might be right for
Acute Low Back Pain
NVP Healthcare 91
Large-scale testing (Phase 3)WithdrawnNCT03315832
What this trial is testing

Efficacy of Angiotensin Receptor Blocker Following aortIc Valve Intervention for Aortic STenOsis: a Randomized mulTi-cEntric Double-blind Phase II Study

Who this might be right for
Aortic Valve StenosisValsartanAngiotensin Receptor Antagonists+3 more
University Hospital, Limoges
Not applicableStudy completedNCT02071563
What this trial is testing

Effectiveness and Cost-Effectiveness of Four Formulations of Food Supplements for the Prevention of Wasting and Stunting in Burkina Faso

Who this might be right for
Child Malnutrition
Tufts University 6,039
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation